Your browser doesn't support javascript.
"Neurological manifestations of COVID-19" - guideline of the German society of neurology.
Berlit, Peter; Bösel, Julian; Gahn, Georg; Isenmann, Stefan; Meuth, Sven G; Nolte, Christian H; Pawlitzki, Marc; Rosenow, Felix; Schoser, Benedikt; Thomalla, Götz; Hummel, Thomas.
  • Berlit P; Secretary General of the German Society of Neurology, Berlin, Germany.
  • Bösel J; Department of Neurology, Klinikum Kassel, DGNI, Kassel, Germany.
  • Gahn G; Department of Neurology, Klinikum Karlsruhe, DGNI, Karlsruhe, Germany.
  • Isenmann S; Department of Neurology and Clinical Neurophysiology, St. Josef Hospital Moers, Moers, Germany.
  • Meuth SG; Department of Neurology, University Hospital Düsseldorf, Düsseldorf,, Germany.
  • Nolte CH; Department of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB) Charité-University Berlin, Berlin, Germany.
  • Pawlitzki M; Department of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
  • Rosenow F; Epilepsy Center Frankfurt Rhein-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Frankfurt, Germany.
  • Schoser B; Friedrich Baur Institute at the Neurological Department, LM-University Munich, Munich, Germany.
  • Thomalla G; Department of Neurology, Head and Neurocenter, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Hummel T; Interdisciplinary Center for Smelling and Tasting, University ENT Hospital Dresden, German Society for ENT Medicine, Dresden, Germany.
Neurol Res Pract ; 2: 51, 2020.
Article in English | MEDLINE | ID: covidwho-954826
ABSTRACT
Infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was first described in the Hubei region of China. The SARS-CoV-2 pandemic has implications for all areas of medicine. It directly and indirectly affects the care of neurological diseases. SARS-CoV-2 infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases. In October 2020, the German Society of Neurology (DGN, Deutsche Gesellschaft für Neurologie) published the first guideline on the neurological manifestations of the new infection. This S1 guideline provides guidance for the care of patients with SARS-CoV-2 infection regarding neurological manifestations, patients with neurological disease with and without SARS-CoV-2 infection, and for the protection of healthcare workers. This is an abbreviated version of the guideline issued by the German Neurological society and published in the Guideline repository of the AWMF (Working Group of Scientific Medical Societies; Arbeitsgemeinschaft wissenschaftlicher Medizinischer Fachgesellschaften).
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Neurol Res Pract Year: 2020 Document Type: Article Affiliation country: S42466-020-00097-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Neurol Res Pract Year: 2020 Document Type: Article Affiliation country: S42466-020-00097-7